IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases.

导出 OA

翻译打印收藏纠错

作者： Sebastian,Hörner ^[1] ; Moustafa,Moustafa-Oglou ^[2] ; Karin,Teppert ^[1] ; Ilona,Hagelstein ^[1] ; Joseph,Kauer ^[2] ; Martin,Pflügler ^[3] ; Kristina,Neumann ^[1] ; Hans-Georg,Rammensee ^[2] ; Thomas,Metz ^[1] ; Andreas,Herrmann ^[2] ; Helmut R,Salih ^[3] ; Gundram,Jung ^[1] ; Latifa,Zekri ^[1]

作者单位： Department of Immunology, Institute for Cell Biology, Eberhard Karls University Tuebingen, German Cancer Consortium (DKTK), Partner Site Tuebingen, 72076 Tuebingen, Germany. ^[1] Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, 72076 Tuebingen, Germany. ^[2] DFG Cluster of Excellence 2180 "Image-guided and Functional Instructed Tumor Therapy" (iFIT), Eberhard Karls University Tuebingen, 72076 Tuebingen, Germany. ^[3] Charles River Discovery Research Services Germany GmbH, 79108 Freiburg, Germany. ^[4] Baliopharm AG, 4051 Basel, Switzerland. ^[5]

关键词 CD19 CD20 CD95 apoptosis autoimmune diseases bispecific antibodies lymphoma

DOI 10.3390/cancers14163941

PMID 36010934

发布时间 2022-08-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交